spacer
home > epc > winter 2003 > translating the pharma industry
PUBLICATIONS
European Pharmaceutical Contractor

Translating the Pharma Industry

The value of translations produced in the UK is thought to be worth more than £161 million according to some definitive research carried out last year. This figure may seem relatively low value compared with the market worth of the pharmaceutical sector as a whole, but considering the volume of actual translation jobs needed to produce such a global figure, translation is far from being an insignificant net contributor to UK plc.

Let's get the rest of the statistics out of the way. The translation profession is split into two segments; companies, of which there are around 1,500, and individual freelancers. It is estimated that there are around 8,000 to 9,000 freelance translators, although there are probably more since many individuals who offer translation or interpreting services rarely join one of the recognised professional bodies. The Association of Translation Companies is the only body regulating the company sector of the profession.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoffrey Bowden, General Secretary of the Association of Translation Companies

Geoffrey Bowden has been the General Secretary of the Association of Translation Companies for 23 years. In addition to his role with the ATC, he runs a successful PR consultancy, Nexus Structured Communications, specialising in the health sector. The client base of the consultancy includes household names in the pharmaceutical industry.

spacer
Geoffrey Bowden
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement